Arcellx Inc (ACLX)
56.19
+1.60
(+2.93%)
USD |
NASDAQ |
Jun 21, 16:00
57.21
+1.02
(+1.81%)
After-Hours: 20:00
Arcellx Stock Buybacks (Quarterly): 0.00 for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | -199.71M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -100.00M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.816M |
| Date | Value |
|---|---|
| June 30, 2022 | -121.49M |
| March 31, 2022 | -139.16M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.024M |
| March 31, 2021 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-199.71M
Minimum
Dec 2023
0.816M
Maximum
Sep 2022
-43.04M
Average
--
Median
Mar 2021
Stock Buybacks (Quarterly) Benchmarks
| Gilead Sciences Inc | 254.00M |
| BridgeBio Pharma Inc | -312.32M |
| Eli Lilly and Co | 0.00 |
| AbbVie Inc | 1.324B |
| Blueprint Medicines Corp | -48.94M |